The Drug Enforcement Agency has just given approval for the first-ever gold standard study in the United States on the relationship between medical marijuana and post-traumatic stress disorder (PTSD).
With DEA approval in hand, researchers will now be able to purchase marijuana for the proposed study. Previously, studies relied on oils or synthetic cannabis, but this study is remarkable because it’s the first randomized controlled trial in the United States using actual marijuana.
The Multidisciplinary Association for Psychedelic Studies (MAPS), the non-profit group sponsoring the study, said researchers will start bringing in study participants hopefully by June. MAPS received around $2 million from Colorado to fund the endeavor.
The effort has been a long time coming, mostly because the regulatory barrier is so extensive. Initial approval was granted by the Department of Health and Human Services in 2014.